One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial

The efficacy and safety of a 1-month prasugrel-based dual antiplatelet therapy (DAPT) strategy followed by reduced-dose prasugrel monotherapy in acute coronary syndrome (ACS) patients treated with drug-coated stents (DCS) have not been studied. We aimed to evaluate the safety and efficacy of a 1-mon...

Full description

Saved in:

Bibliographic Details
Published in:	EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Vol. 21; no. 14; p. e796
Main Authors:	Jang, Youngwoo, Park, Sang-Don, Lee, Joon Pyo, Choi, Seong Huan, Kong, Min Gyu, Won, Yoon Sun, Kim, Minsu, Lee, Kyoung Hoon, Han, Seung Hwan, Kwon, Sung Woo, Suh, Jon, Kang, Woong Chol
Format:	Journal Article
Language:	English
Published:	France 21.07.2025
Subjects:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - therapy Aged Aspirin - administration & dosage Aspirin - adverse effects Aspirin - therapeutic use Drug Therapy, Combination Drug-Eluting Stents Dual Anti-Platelet Therapy - methods Female Hemorrhage - chemically induced Humans Male Middle Aged Percutaneous Coronary Intervention - methods Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - adverse effects Prasugrel Hydrochloride - therapeutic use Treatment Outcome
ISSN:	1969-6213, 1969-6213
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!